Prim, S.A. (BME:PRM)

Market Cap	221.18M +22.1%
Revenue (ttm)	251.89M +7.9%
Net Income	16.68M +52.8%
EPS	0.98 +53.1%
Shares Out	17.01M
PE Ratio	13.27
Forward PE	11.24
Dividend	0.47 (3.57%)
Ex-Dividend Date	Mar 10, 2026

Volume	917
Average Volume	2,405
Open	13.20
Previous Close	13.00
Day's Range	12.95 - 13.20
52-Week Range	10.65 - 13.95
Beta	0.52
RSI	45.37
Earnings Date	Sep 9, 2026

About Prim, S.A.

Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 984
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: PRM

Financial Performance

In 2025, Prim, S.A.'s revenue was 251.89 million, an increase of 7.94% compared to the previous year's 233.36 million. Earnings were 16.68 million, an increase of 52.77%.